We are a French biotechnology company specializing in oligonucleotide therapeutics, offering an end-to-end drug discovery platform from design to manufacturing transfer. Our expertise spans ASOs, siRNA, RNAi, miRNA, and G-quadruplexes across multiple therapeutic areas. With proprietary technology and flexible collaboration models, we support external partners through fee-for-service or co-development. Focused on innovation and speed, we provide customized solutions to accelerate the development of next-generation therapeutics.